Announcements Trials
Browse Landscape

Phase

Phase 1/2 2Phase 2 1

Status

Terminated 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 34Other hematologic neoplasm 23Thoracic 16CNS 16Breast 14Sarcoma 9Dermatologic 8Genitourinary 7Plasma cell 6Myeloid 6Head & Neck 5Gastrointestinal 5Gynecologic 3Classical hematology 3Tumor-Agnostic 2Other solid neoplasm 1Endocrine 1

Conditions

Ovarian Neoplasms 2Leiomyosarcoma 1Fallopian Tube Neoplasms 1Endometrial Stromal Tumors 1

Interventions

Paclitaxel 153Carboplatin 123Bevacizumab 87Cisplatin 66pembrolizumab 58Taxes 51Gemcitabine 51liposomal doxorubicin 39Topotecan 37olaparib 31Immunoglobulin G 27Disulfides 26Cyclophosphamide 24Brachytherapy 22Docetaxel 21human papillomavirus vaccine, L1 type 16, 18 20niraparib 19Platinum 19Nivolumab 18Magnetic Resonance Spectroscopy 181,2-diaminocyclohexaneplatinum II citrate 18rucaparib 17durvalumab 16Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 16Doxorubicin 16Radiotherapy, Intensity-Modulated 14Radiation 13Albumin-Bound Paclitaxel 13fludarabine phosphate 12fludarabine 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Has results × Vorinostat × Gynecologic × Clear all
NCT03509207 2020-08-04

Vorinostat (SAHA) in Uterine Sarcoma

Medical University of Graz

Phase 2 Terminated
3 enrolled 6 charts
GynecologicSarcoma

Leiomyosarcoma, Endometrial Stromal Tumors

NCT00910000 2018-09-10

Vorinostat, Carboplatin and Gemcitabine in Women With Recurrent, Platinum-Sensitive Ovarian Cancer

Dana-Farber Cancer Institute

Phase 1/2 Terminated
15 enrolled 12 charts
Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT00976183 2017-04-10

Paclitaxel, Carboplatin and Vorinostat for the Treatment of Advanced Stage Ovarian Carcinoma

Gynecologic Oncology Associates

Phase 1/2 Terminated
18 enrolled 7 charts
Gynecologic

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡